0
Summaries for Patients |

Botulinum Toxin as a Treatment for Tennis Elbow FREE

[+] Article and Author Information

The summary below is from the full report titled “Treatment of Lateral Epicondylitis with Botulinum Toxin. A Randomized, Double-Blind, Placebo-Controlled Trial.” It is in the 6 December 2005 issue of Annals of Internal Medicine (volume 143, pages 793-797). The authors are S.M. Wong, A.C.F. Hui, P.-Y. Tong, D.W.F. Poon, E. Yu, and L.K.S. Wong.


Ann Intern Med. 2005;143(11):I-48. doi:10.7326/0003-4819-143-11-200512060-00003
Text Size: A A A

What is the problem and what is known about it so far?

Tennis elbow (lateral epicondylitis) is a frequent cause of elbow pain. Repetitive use of the arm, especially repeated extension of the wrist and elbow, causes strain and inflammation of muscles and tendons. These movements are common in many activities besides tennis. Commonly used treatments include nonsteroidal anti-inflammatory drugs, physical therapy, corticosteroid injections, and surgery. Researchers do not know if any of these therapies are really effective because tennis elbow eventually improves by itself. Botulinum toxin (which is often referred to by one of its brand names, “Botox”) is another potential treatment. Botulinum toxin is a protein produced by bacteria that blocks conduction of nerve impulses. It may reduce pain by blocking the nerve impulses that cause painful muscle spasms. Small studies suggest that botulinum toxin is an effective treatment for tennis elbow, but the studies are not definitive.

Why did the researchers do this particular study?

To determine if botulinum toxin is an effective treatment for tennis elbow.

Who was studied?

60 adults who had tennis elbow for at least 3 months and who came to 2 large medical centers in Hong Kong for treatment.

How was the study done?

The researchers assigned patients at random to receive injections with botulinum toxin or saltwater placebo. They asked the patients to rate their pain before the injection and again 1 and 3 months after treatment. They measured handgrip strength at the same times. They then compared the measures in the 2 groups.

What did the researchers find?

Botulinum toxin significantly improved pain 1 and 3 months after treatment but made no difference in handgrip strength. The toxin appeared to cause weakness in the arms of 10 patients at 1 month; most patients were better at 3 months. Doctors confirmed actual loss of function in the fingers of 4 patients at 1 month and in 1 patient at 3 months.

What were the limitations of the study?

Many of the patients had severe cases of tennis elbow that lasted for many months. The findings might not apply to patients with less severe cases of the disorder. Accurate measures of the effect of treatments in a trial depend on patients not knowing which treatment they received. The patients in whom botulinum toxin caused weakness may have suspected that they received active treatment. As a result, they may have been more inclined to report improvements in pain.

What are the implications of the study?

Botulinum toxin appears to be effective for up to 3 months as a treatment for lateral epicondylitis, but it may cause weakness and loss of hand function in a very small number of people.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)